Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Percheron Therapeutics Ltd PER


Primary Symbol: PERCF

Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a biotechnology company. The Company is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Company’s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS). ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. ATL1103 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood and is a potential treatment for diseases associated with excessive growth hormone action. By inhibiting GHr production, ATL1103 in turn reduces IGF-I levels in the blood (serum). The Company is conducting a Phase II clinical trial of ATL1102 in DMD patients.


OTCPK:PERCF - Post by User

Bullboard Posts
Post by SailorSailoron Jul 19, 2001 9:28am
127 Views
Post# 4003923

Perot Systems Sign a 12-Year

Perot Systems Sign a 12-Year Perot Systems and The Robert Plan Sign a 12-Year, $185 Million IT Services Agreement 7/19/01 * Strengthening an Alliance Already 12 Years Old * BETHPAGE, N.Y. and DALLAS, Jul 19, 2001 /PRNewswire via COMTEX/ -- The Robert Plan Corporation, a leading provider of insurance services to the property-casualty insurance industry and the acknowledged expert in managing assigned risk auto insurance industries, today signed a 12-year, $185 million contract with worldwide IT services and solutions provider, Perot Systems Corporation (NYSE: PER). The alliance will extend an existing 12-year IT services relationship for 12 more years. Under the new contract
Bullboard Posts